News & Events
CHANGES OF CORPORATE OFFICERS
For Print (PDF) <Changes of Corporate Officers, effective July 10, 2023> New Responsibility Current Responsibility Name Senior Vice President Acting President, Americas Region Acting Chairman & CEO, Eisai Inc. Senior Vice President Chief Financial Officer Chief IR Officer Tatsuyuki Yasuno Senior Vice President Chief Government Relations Officer Chief IR Officer Global Value & Access General […]
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
The first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline in adults with Alzheimer’s disease The Centers for Medicare & Medicaid Services (CMS) announced broader Medicare coverage of LEQEMBI For Print (PDF) TOKYO and CAMBRIDGE, Mass., July 6, 2023 – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and […]
EISAI TRANSFERS ALL FUTURE ECONOMIC RIGHTS FOR ELACESTRANT, A SELECTIVE ESTROGEN RECEPTOR DEGRADER, TO DRI HEALTHCARE
For Print (PDF) Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to transfer all future economic rights for elacestrant (generic name), approved for the treatment for breast cancer in the United States, to DRI Healthcare Trust (Headquarters: Ontario, Canada, “DRI Healthcare”). Elacestrant is a selective […]
NEW NEURII RESEARCH COLLABORATION BETWEEN EISAI, GATES VENTURES, HEALTH DATA RESEARCH UK, LIFEARC AND THE UNIVERSITY OF EDINBURGH TO DEVELOP DIGITAL SOLUTIONS FOR DEMENTIA IS ANNOUNCED
For Print (PDF) New research collaboration brings together world-leading institutions’ collective expertise in therapeutics, technology, health data, technology commercialisation and advanced analytics/data science in neurology. Two-year pilot provides a launch pad for translating scientific prototypes into practical solutions that demonstrate real-world impact. NEURii collaboration builds on Eisai’s extensive experience in delivering innovative treatments in neurology […]
FAQs
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
We Take Care
Important Information
The information provided on this website is for educational and informational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified Doctor with any questions you may have regarding a medical condition.
New and Better Treatment
Very Safe and Well-Tested
Patient-Centric Design
